Milestone Pharmaceuticals Inc (MIST)
1.74
-0.01
(-0.57%)
USD |
NASDAQ |
May 17, 16:00
1.74
0.00 (0.00%)
After-Hours: 20:00
Milestone Pharmaceuticals Total Assets (Quarterly): 96.00M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 96.00M |
| December 31, 2023 | 75.23M |
| September 30, 2023 | 87.12M |
| June 30, 2023 | 97.02M |
| March 31, 2023 | 111.08M |
| December 31, 2022 | 74.48M |
| September 30, 2022 | 85.77M |
| June 30, 2022 | 91.30M |
| March 31, 2022 | 105.80M |
| December 31, 2021 | 119.85M |
| September 30, 2021 | 133.78M |
| Date | Value |
|---|---|
| June 30, 2021 | 145.50M |
| March 31, 2021 | 138.44M |
| December 31, 2020 | 149.97M |
| September 30, 2020 | 108.80M |
| June 30, 2020 | 93.14M |
| March 31, 2020 | 105.16M |
| December 31, 2019 | 123.43M |
| September 30, 2019 | 141.89M |
| June 30, 2019 | 151.84M |
| March 31, 2019 | 77.59M |
| December 31, 2018 | 88.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
74.48M
Minimum
Dec 2022
151.84M
Maximum
Jun 2019
111.78M
Average
107.30M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 56.08M |
| Shareholders Equity (Quarterly) | 39.92M |